NCT06398015

Hip Abductor Tendon Repair Versus Sham Surgery

Open Surgical Reconstruction Versus Open Sham Surgery in the Treatment of Hip Abductor Tendon Tears; A Double Blinded, Randomized Controlled Trial
Horsens Hospital·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Surgical reconstruction of hip abductor tendon tear
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Horsens Hospital
Location
Horsens, Denmark
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Feb 01, 2027
Enrollment
36 participants
Primary outcome

Differences in changes in patient-reported pain measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

Summary

This study will examine the effectiveness of open surgical reconstruction in the treatment of
 patients with hip abductor tendon tears. Patients will be randomly allocated to either the
 open surgical reconstruction or to a open surgical sham procedure. The primary outcome is
 patient reported pain measured by the revised Copenhagen Hip And Groin Outcome Score (HAGOS),
 which will be conducted pre-surgery and at three and six months post-surgery. The six-month
 follow-up is the primary endpoint.

ICD-10 classifications
Injury of muscle and tendon of hipSpontaneous rupture of unspecified tendonInjury of muscle and tendon at hip and thigh levelSpontaneous rupture of other tendonsSpontaneous rupture of flexor tendons
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06398015
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06398015 through Pure Global AI's free database. This phase not specified trial is sponsored by Horsens Hospital and is currently Recruiting. The study focuses on Rupture of Hip Abductor Tendon (Disorder). Target enrollment is 36 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.